ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Kalmegh Ghana

Also known as: Kalmegh, Green Chiretta, King of Bitters, Andrographis paniculata

Overview

Andrographis paniculata, commonly known as Kalmegh, is a bitter-tasting herb native to Asia, widely utilized in traditional Ayurvedic and Unani medicine. It is primarily recognized for its anti-inflammatory, antioxidant, and immune-modulating properties. The plant contains active compounds, notably andrographolide, which are believed to be responsible for its diverse pharmacological effects. Research into Kalmegh's health benefits is ongoing, with a moderate but growing body of evidence supporting its traditional uses. While some studies show promising results, particularly in areas like liver health and immune support, more rigorous and extensive clinical trials are needed to fully establish its efficacy and safety across various applications. It is available in various forms, including capsules and extracts.

Benefits

Kalmegh primarily offers anti-inflammatory and immune-modulating effects. Research suggests it may be beneficial in reducing liver enzymes and improving lipid profiles in conditions such as non-alcoholic fatty liver disease (NAFLD), with some studies indicating significant improvements in these markers. The strength of evidence for these benefits is moderate, with promising results from initial studies, though larger, more rigorous trials are needed. Andrographolide, a key compound in Kalmegh, has also demonstrated potential anticancer properties in in vitro studies, particularly against colon cancer cells, though human trials are required to confirm these effects. Individuals with liver conditions or those seeking immune support may benefit most from Kalmegh. Benefits may become apparent within weeks to months of consistent use.

How it works

Kalmegh exerts its effects primarily through anti-inflammatory pathways, immune modulation, and antioxidant mechanisms. Its active compound, andrographolide, interacts with various cellular targets to mediate these effects. It is known to influence the liver and immune system, and potentially the gut, by modulating inflammatory responses and enhancing immune function. While the exact molecular targets are still being elucidated, andrographolide is thought to interfere with signaling pathways involved in inflammation and immune cell activation. Data on its absorption and bioavailability are limited, suggesting a need for further research to fully understand its pharmacokinetics and optimize its delivery within the body.

Side effects

Kalmegh is generally considered safe when used appropriately, but some side effects and precautions should be noted. The most common side effects are mild gastrointestinal upset, which is rare. Allergic reactions are uncommon but possible. Rare side effects are not well-documented. Kalmegh may interact with certain medications, including blood thinners, potentially increasing the risk of bleeding, and diabetes medications, which could affect blood sugar levels. Therefore, individuals on these medications should exercise caution and consult a healthcare professional. It is contraindicated during pregnancy and breastfeeding due to a lack of sufficient safety data. Individuals with autoimmune diseases should also use Kalmegh with caution, as its immune-modulating effects could potentially exacerbate their condition. Always consult a healthcare provider before starting Kalmegh, especially if you have pre-existing health conditions or are taking other medications.

Dosage

The minimum effective dose for Kalmegh is not well-established, but it is typically used in a range of 300-1200 mg per day. Optimal dosage ranges are variable and require further research for precise determination. While a maximum safe dose is not clearly defined, caution is advised when exceeding 1200 mg per day. To minimize the potential for gastrointestinal upset, it is generally recommended to take Kalmegh with meals. It is commonly available in capsule or extract forms. Absorption may be enhanced when taken with fatty meals, though specific cofactors are not documented as required. It is always advisable to start with a lower dose and gradually increase while monitoring for any adverse effects, and to consult a healthcare professional for personalized dosing recommendations.

FAQs

How should I start taking Kalmegh?

It is recommended to start with a low dose of Kalmegh and gradually increase it while monitoring for any side effects. Consult a healthcare professional for personalized guidance.

Is Kalmegh safe during pregnancy or breastfeeding?

No, Kalmegh is contraindicated during pregnancy and breastfeeding due to a lack of sufficient safety data. It is best to avoid its use during these periods.

When is the best time to take Kalmegh?

To reduce the potential for gastrointestinal upset, it is best to take Kalmegh with meals. This may also help enhance its absorption.

How long does it take to see benefits from Kalmegh?

The benefits of Kalmegh may not be immediately apparent. It can take several weeks to months of consistent use to notice its effects.

Is Kalmegh a cure-all for health issues?

No, Kalmegh is not a cure-all. While it has potential benefits, it should be used under medical supervision and as part of a comprehensive health plan.

Research Sources

  • https://www.postersessiononline.eu/173580348_eu/congresos/ILC2023/aula/-FRI_530_ILC2023.pdf – This study investigated Kalmegh supplementation in patients with non-alcoholic fatty liver disease (NAFLD). It reported improvements in lipid profiles and liver enzyme levels, with no adverse effects observed. However, the study was limited by its small sample size and lack of long-term follow-up, indicating a need for further research.
  • https://ctppc.org/article-details/17756 – This research explored the anticancer properties of andrographolide, a compound found in Kalmegh. The findings demonstrated in vitro anticancer effects, particularly against colon cancer cells. It's important to note that these are in vitro results, and human trials are necessary to confirm these effects in living organisms.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC12000883/ – This study examined the effects of Kalmegh extracts on immune responses and inflammation in gut health models. The results indicated that Kalmegh could enhance immune function and reduce inflammation. However, these findings are based on animal studies, and human trials are required to validate these effects in humans.

Supplements Containing Kalmegh Ghana

Liv-First by Herbal Hills
68

Liv-First

Herbal Hills

Score: 68/100